IDH1 and central nervous system cancer: According to the 2016 WHO update, gliomas are classified as contained gliomas (WHO grade I) or diffusely infiltrating gliomas (WHO grade II–IV) based on their development pattern and the presence or absence of an isocitrate dehydrogenase (IDH) mutation [2].